COVID-19

  • Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
  • Applicant/Recipient COVID-19 Update History
  • CDC COVID-19
  • Get the latest research information from NIH | Español
Expand for resources

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

  • U.S. Department of Health & Human Services
  • National Institutes of Health
Grants Home
  • eRA  |  new windowwNIH Staff   |  Glossary  |  FAQs  |  Help
  • Home
  • About Grants
    • Grants Process Overview
    • Get Started

    • Learn the Basics
    • Plan Your Application
    • How to Apply

    • Prepare to Apply
    • Write Application
    • Submit
    • How to Apply Video Tutorials

      Application Referral and Review

    • Receipt and Referral
    • Peer Review
    • Pre-Award and Post-Award Processes

    • Pre-Award and Award Process
    • Post Award Monitoring and Reporting
    • Forms Library

      Information For

    • Researchers
    • Research Administrators
    • Reviewers
    • Small Businesses Link to External Site
    • Foreign Grants
    • Media and the Public
    • NIH Staff Lock Icon
  • Funding
    • Find Grant Funding (NIH Guide to Grants and Contracts)
    • Other Transactions
    • Contracts
    • Research Training and Career Development Link to External Site
    • Loan Repayment Programs Link to External Site
    • Extramural Diversity Link to External Site
    • NIH Funding Strategies




      Notice IconAvoid Grant Scams
  • Policy & Compliance
    • NIH Grants Policy Statement
    • Notices of Policy Changes
    • Compliance & Oversight
    • Policy Topics

    • Animal Welfare Link to External Site
    • Application Submission Policies
    • Clinical Trial Requirements
    • Coronavirus Disease 2019 (COVID-19)
    • Early Stage Investigator Policies
    • Family-Friendly Initiatives
    • Financial Conflict of Interest
    • Human Subjects Research
    • Inclusion Policies
    • Intellectual Property Policy
    • Lobbying Guidance for Grantee Activities
    • Natural Disasters
    • NIH Funding Strategies
    • Peer Review Policies and Practices
    • Protecting U.S. Biomedical Intellectual Innovation
    • Public Access Link to External Site
    • Research Integrity
    • Resources to Evaluate Workplace Climate
    • Rigor and Reproducibility
    • Sharing Policies Link to External Site
    • Supporting a Safe and Respectful Workplace
  • News & Events

      Latest News

    • News Highlights
    • "Open Mike" Blog Link to External Site
    • Extramural Nexus Link to External Site
    • Subscribe and Follow

    • Listservs
    • Social Media

      Virtual Learning

    • Webinars
    • Podcasts
    • NIH Grants YouTube Channel Link to External Site

      Connect In Person

    • NIH Regional Seminars on Program
      Funding & Grants Administration
    • SBIR-STTR Engage & Connect Link to External Site
    • Loan Repayment Program (LRP)
      Contact & Engage
       Link to External Site
    • Office of Laboratory Animal Welfare (OLAW)
      Workshops and Conference
      Link to External Site
    • Events Calendar
  • About OER
    • About the Office of Extramural Research
    • OER Offices

    • Immediate Office of the Director (IMOD)
    • Office of Policy for Extramural Research Administration (OPERA)
    • Office of Research Reporting and Analysis (ORRA)
    • Office of Laboratory Animal Welfare (OLAW)
    • Strategic Management and Contracts Office (SMCO)
    • Office of Electronic Research Administration (eRA)
    • Division of Communication & Outreach (DCO)
    • Small Business Education and Entrepreneurial Development (SEED)
    • Division of Biomedical Research Workforce (DBRW)
    • Division of Human Subjects Research (DHSR)
  • eRA
    Link to External Site
  • NIH Staff Lock Icon
  • Home
  • FAQs
  • Help

Policy & Compliance

  • NIH Grants Policy Statement
  • Notices of Policy Changes
  • Compliance & Oversight
  • Select Policy Topics+
    • Animal Welfare
    • Application Submission Policies
    • Clinical Trial Requirements+
      • Clinical Trial Definition
      • Why the Changes
      • Good Clinical Practice
      • Specific Funding Opportunities
      • New Form
      • Single IRB Policy
      • Protocol Template
      • Registration and Reporting
    • NIH Funding Strategies
    • Human Subjects Research
    • Intellectual Property Policy
    • Lobbying Guidance for Grantee Activities
    • Early Stage and Early Established Investigator Policies
    • Peer Review Policies and Practices
    • Public Access
    • Research Integrity
    • Anti-Sexual Harassment
    • Sharing Policies
Home  »   Policy & Compliance   »  Office of Laboratory Animal Welfare   »  Suggestions to Bring Electronic Protocol System into Compliance - From: Contemporary Topics of November 8, 2001
Office of Laboratory Animal Welfare
Suggestions to Bring Electronic Protocol System into Compliance

From: Contemporary Topics
40(6): 8, November, 2001


To the Editor:

The NIH Office of Laboratory Animal Welfare (OLAW) and USDA/APHIS, Animal Care (AC) have reviewed the September 2001 Contemporary Topics article, "A Novel Interactive Electronic Protocol System" by Lewis, et al [40(5): 14-16]. We recognize the many positive innovative and burden-reducing elements in the system. We also recognize that there are circumstances under which the PHS Policy on Humane Care and Use of Laboratory Animals (PHS Policy) and/or the Animal Welfare Act Regulations (AWAR) do not apply. Nevertheless, both OLAW and AC find elements of the system, as described, to be noncompliant with the federal requirements for protocol review. Relatively minor modifications of the described system could be made to make it fully compliant and consistent with previous published guidance on the subject (see Lab Animal letter to the editor March 2001 http://www.labanimal.com/letters/garnett.html).

Because many readers of Contemporary Topics are subject to these federal requirements, we believe that clarification of these inconsistencies is essential. PHS-Assured institutions are reminded that failure to comply with PHS Policy IACUC review provisions could result in invalidation of IACUC approvals and constitute violation of the terms and conditions of PHS awards.

Under the PHS Policy and AWAR there are only two protocol review models: full-committee review and designated-member review. The "Novel Interactive Electronic Protocol System" (NIEPS) appears to be a hybrid of these two review methods, and fails to fully satisfy the requirements of either system.

The NIEPS does not meet the full committee review model because full review must occur in real-time and with a convened quorum of the IACUC participating (see ILAR Journal 37(4): 190-192; https://grants.nih.gov/grants/olaw/references/ilar95.htm). Further, the NIEPS article states that any member may call for full review, suggesting that the NIEPS itself is not intended to emulate the full review mode.

In the designated-member mode, reviewer(s) may only "approve, require modifications in (to secure approval), or request full committee review." Designated reviewers technically do not "vote." If the NIEPS is attempting to follow the designated reviewer model, with all members being treated as designated reviewers, then every member must respond with one of the above three options. Under these circumstances, a quorum of designated reviewers approving the protocol is not sufficient and approval by all is required. If modifications occur at any stage of the review, all designated reviewers must see and approve them; otherwise reviewers could be approving substantially different protocols. In the NIEPS, it appears possible for a majority of members to approve the proposal early in the 5-day review period, preempting questions that might have been raised by other members later in the 5-day period.

In order to modify the NIEPS to conform to federal requirements, it is first necessary to clearly recognize which mode of review (full or designated) is being emulated. The appropriate procedures, in the required sequence (as described in PHS Policy and AWAR) can then be designed into the system. In this case, such modifications would appear to be minor and would not substantially diminish the intended benefits.

For example, the NIEPS could meet the procedural requirements of the designated member mode if, instead of an online vote, an official designated reviewer, selected by the Chair, made the final approval decision. That person's approval would be informed by all of the electronic discussions and modifications that occurred. Alternatively, if all members are considered designated reviewers, and all have had the opportunity to call for full review, the approval of the final version of the protocol by all, without further modification, would satisfy federal procedural requirements.

Although technologically more difficult, the functional equivalent of a convened quorum in the full committee mode might be emulated through real-time, interactive, video-conferencing added to the end of the described electronic review process. This possibility, under exceptional circumstances, has been alluded to in the previously referenced ILAR publication.

We would be pleased to collaborate with institutions and organizations in the design of model electronic protocol review systems that are consistent with PHS/USDA requirements.

Nelson Garnett, DVM, Director, NIH, Office of Laboratory Animal Welfare

Chester Gipson, DVM, Acting Deputy Administrator, USDA, APHIS, Animal Care

This page last updated on May 24, 2004 
Content Manager: olaw@od.nih.gov 
Technical Issues: E-mail OER Webmaster   

Back to Top
  • Contact Us
  • Bookmark & Share
  • E-mail Updates
  • RSS Feed
  • Podcast
  • Twitter
  • YouTube

  • Search
  • Help Downloading Files
  • Disclaimer
  • Older Versions of this Page
  • Privacy Notice
  • Accessibility
  • HHS Vulnerability Disclosure
  • FOIA
  • U.S. Department of Health and Human Services
  • Grants.gov
  • USA.gov - Government Made Easy


  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health